Plaque Erosion with No Stenting in Acute Coronary Syndrome: Are There Event Predictors to Avoid This Strategy?

 Event predictors in patients with plaque erosion and no stenting.


A third of all acute coronary syndrome (ACS) cases are caused by plaque erosion. In the initial EROSION study, it was shown that patients with plaque erosion (as evidenced by OCT, with stenosis <70%, TIMI III flow, and asymptomatic) were stabilized without stent implantation (no stenting strategy), with antiplatelet therapy using aspirin and ticagrelor. In turn, the 4-year follow-up of this study showed an incidence of major adverse cardiovascular events (MACE) of 23.1%.

Erosión de placa con “no stenting” en el síndrome coronario agudo: ¿Existen predictores de eventos para evitar esta estrategia?

The aim of the study by Yin Y. et al. was to compare the predictors of adverse events with this type of strategy in a retrospective cohort from one center and the historical cohort of the EROSION study (232 patients in total). Patients were divided into two groups according to the occurrence or not of MACE. Patients with ST-elevation, non-ST-elevation, and unstable angina (pretreated with aspirin, ticagrelor, and unfractionated heparin) were included.

Of the 232 ACS patients included, 21.6% had experienced a MACE event (composite outcome of cardiac death, recurrent acute myocardial infarction, ischemia-guided revascularization, rehospitalization for angina, major bleeding, or stroke) at the 2.9-year follow-up. Patients with MACE were older (55.7 vs. 51 years; p = 0.004) and with higher prevalence of diabetes (18% vs. 8.8%; p = 0.063). When analyzing OCT data, those patients with events had lower prevalence of presence of a fibrous plaque (6% vs. 22%, p = 0.010), higher thrombotic burden (24.4% vs. 20.4%; p = 0.010), smaller minimal luminal area (2.3 vs. 2.9, p = 0.001), and higher stenosis area percentage (SA%) (72.2% vs. 64.2%, p ≤ 0.001).

Read also: Uncomplicated Type B Aortic Dissection.

With a multivariate analysis, researchers observed that age (hazard ratio [HR]: 1.035; 95% confidence interval [CI]: 1.005-1.065; = 0.021), SA% (HR: 1.043; 95% CI: 1.015-1.071; p = 0.003) and thrombotic burden (HR: 1.026; 95% CI: 1.001-1.053; p = 0.044) were event predictors. In turn, they analyzed with an ROC curve the best cutoff points for the definition of events, which were age >60 years, SA% ≥63.5%, and thrombotic burden ≥18.5%. The MACE rate with these three predictors present was 57.7%.

Conclusions

Patients with ACS selected for the no stenting strategy had a MACE rate of 21.6%, with the predictors for clinical outcomes being age >60 years, SA% >63.5%, and thrombotic burden >18.5%. Therefore, these characteristics should be taken into account before deciding to omit stenting.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the editorial board of SOLACI.org.

Original Title: Predictors of Adverse Prognosis in Patients With Acute Coronary Syndrome Caused by Plaque Erosion With a Nonstent Strategy.

Reference: Yin Y, Lei F, Fang C, Jiang S, Xu X, Sun S, Pei X, Jia R, Tang C, Peng C, Li S, Li L, Wang Y, Yu H, Dai J, Yu B. Predictors of Adverse Prognosis in Patients With Acute Coronary Syndrome Caused by Plaque Erosion With a Nonstent Strategy. J Am Heart Assoc. 2022 Dec 20;11(24):e026414. doi: 10.1161/JAHA.122.026414. Epub 2022 Dec 19. PMID: 36533592; PMCID: PMC9798785.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....